Compensation
$200 per visit + $300 dosing day
Ages
18 to 70 years
Gender
Male & Female
Trial Setting
Outpatient
Duration
52 weeks
Phase 3 study evaluating oral study drug compared with placebo for the treatment of Major Depressive Disorder in adults.
The Details
- 12-week treatment + 40-week open-label extension
- 18 to 70 years
- Male & Female
- $200 per visit + $300 dosing day
- Outpatient
Participants Must:
Compensation Information:
$200 per visit + $300 dosing day
Apply Today
"*" indicates required fields